
### [NCIT:C40226](http://purl.obolibrary.org/obo/NCIT_C40226)
**Label:** Cervical Mixed Epithelial and Mesenchymal Neoplasm

**Subclasses:** [NCIT:C36097](http://purl.obolibrary.org/obo/NCIT_C36097) (Cervical Carcinosarcoma), [NCIT:C40230](http://purl.obolibrary.org/obo/NCIT_C40230) (Cervical Adenofibroma), [NCIT:C40231](http://purl.obolibrary.org/obo/NCIT_C40231) (Cervical Adenomyoma), [NCIT:C40229](http://purl.obolibrary.org/obo/NCIT_C40229) (Cervical Adenosarcoma), [NCIT:C40227](http://purl.obolibrary.org/obo/NCIT_C40227) (Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C40228](http://purl.obolibrary.org/obo/NCIT_C40228) (Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm), 

**Class expressions from DL-Learner:**

- [UBERON:0000995](http://purl.obolibrary.org/obo/UBERON_0000995) (uterus) 55.00%
- [UBERON:0000474](http://purl.obolibrary.org/obo/UBERON_0000474) (female reproductive system) 55.00%
- [UBERON:0000002](http://purl.obolibrary.org/obo/UBERON_0000002) (uterine cervix) 55.00%
- Thing 53.22%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C132819](http://purl.obolibrary.org/obo/NCIT_C132819) (Stage III Nasopharyngeal Carcinoma AJCC v8))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C132818](http://purl.obolibrary.org/obo/NCIT_C132818) (Stage II Nasopharyngeal Carcinoma AJCC v8))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C132817](http://purl.obolibrary.org/obo/NCIT_C132817) (Stage I Nasopharyngeal Carcinoma AJCC v8))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C132787](http://purl.obolibrary.org/obo/NCIT_C132787) (Stage IV Major Salivary Gland Cancer AJCC v8))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C132786](http://purl.obolibrary.org/obo/NCIT_C132786) (Stage III Major Salivary Gland Cancer AJCC v8))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C132785](http://purl.obolibrary.org/obo/NCIT_C132785) (Stage II Major Salivary Gland Cancer AJCC v8))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C132783](http://purl.obolibrary.org/obo/NCIT_C132783) (Stage 0 Major Salivary Gland Cancer AJCC v8))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C132781](http://purl.obolibrary.org/obo/NCIT_C132781) (Stage I Major Salivary Gland Cancer AJCC v8))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C132732](http://purl.obolibrary.org/obo/NCIT_C132732) (Stage IV Lip and Oral Cavity Cancer AJCC v8))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C132731](http://purl.obolibrary.org/obo/NCIT_C132731) (Stage III Lip and Oral Cavity Cancer AJCC v8))) 40.36%


